Skip to the page

Data / New clinical trials / Weight Loss

New Weight Loss clinical trials: 260 posted since Nov 2024

The full list. New Weight Loss clinical trials: 260 rows for $13, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 14 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/weight-loss, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

260 clinical studies in Weight Loss were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 55 have an industry sponsor and 156 are recruiting or about to. The newest, NCT07926152, was posted on November 9, 2026: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (German Diabetes Center).

The request: Every new Weight Loss clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

  • 260New trials
  • 55Industry sponsored
  • 156Recruiting or not yet
  • November 9, 2026Latest posted

Newest trials

The newest 100 of 260, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First postedNCT IDTitleSponsorPhaseStatusConditionsEnrollmentCountriesSource
November 9, 2026NCT07926152Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesGerman Diabetes CenterNot applicableNot yet recruitingType 2 Diabetes (T2DM), Obesity & Overweight, Sarcopenia94Germanyclinicaltrials.gov
November 3, 2026NCT07913685The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight...Medical University of BialystokPhase 4CompletedObesity & Overweight83Polandclinicaltrials.gov
November 3, 2026NCT07912255Intermittent Fasting and Anthropometric ParametersMasaryk UniversityNot applicableCompletedIntermittent Fasting, Body Weight, and Body Composition95Czechiaclinicaltrials.gov
November 2, 2026NCT07911150Gut-Liver-Muscle Axis in Cancer CachexiaUniversity of Colorado, DenverNot applicableNot yet recruitingHead & Neck Cancer20United Statesclinicaltrials.gov
November 2, 2026NCT07911046Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent ObesityErin MauneyObservationalNot yet recruitingPediatric Obesity, Obesity12United Statesclinicaltrials.gov
November 2, 2026NCT07909889Semaglutide for Weight Management During Hormone Therapy for Early Breast CancerAarhus University HospitalPhase 2Not yet recruitingBreast Cancer (Early Breast Cancer), Obesity32Denmarkclinicaltrials.gov
October 28, 2026NCT07901777Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With ObesityYuzuncu Yil UniversityObservationalRecruitingObesity & Overweight200Turkey (Türkiye)clinicaltrials.gov
October 28, 2026NCT07900178Sustaining Health After an Intensive Weight-loss Pro-grammeCopenhagen University Hospital, HvidovreObservationalEnrolling by invitationObesity & Overweight, Weight Loss, Weight Management in Adult Patients With Obesity or Overweight150Denmarkclinicaltrials.gov
October 28, 2026NCT07900074Mechanisms of Weight Loss: Tirzepatide vs SemaglutideMcMaster UniversityPhase 4RecruitingObesity (Disorder)80Canadaclinicaltrials.gov
October 27, 2026NCT07897890Testing Health-Related Interventions: Voices of Equity Needed to Overcome Weight-bias in Obesity-Cancer CareIndiana UniversityNot applicableCompletedObesity & Overweight, Breast Cancer12United Statesclinicaltrials.gov
October 27, 2026NCT07897383Investigating the Effects of 24 Hour LEAP2 Infusion in Individuals With Overweight and ObesityUniversity Hospital, Gentofte, CopenhagenPhase 1/2Not yet recruitingObesity & Overweight18clinicaltrials.gov
October 22, 2026NCT07890376A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesEli Lilly and CompanyPhase 2Not yet recruitingObesity, Overweight460Argentina, United Statesclinicaltrials.gov
October 22, 2026NCT07888075Master Protocol for the Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or...AVEO Pharmaceuticals, Inc.Phase 2/3Not yet recruitingCachexia; Cancer, Cachexia, Cachexia-Anorexia Syndrome, Metastatic Colorectal Cancer (CRC), Metastatic Non-small Cell...950clinicaltrials.gov
October 20, 2026NCT0788301815-years Outcomes of Sleeve Gastrectomy on Weight LossCentre Hospitalier Universitaire, AmiensObservationalRecruitingBariatric Surgery, Sleeve Gastrectomy, Weight Loss300Franceclinicaltrials.gov
October 19, 2026NCT07880691Weight Loss and Comorbidity Outcomes After Revisional Bariatric SurgeryKasr El Aini HospitalObservationalCompletedObesity, Morbid, Weight Regain After Bariatric Surgery, Insufficient Weight Loss After Bariatric Surgery, Complication...96clinicaltrials.gov
October 15, 2026NCT07874633A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or...PfizerPhase 3RecruitingObesity, Overweight432Chinaclinicaltrials.gov
October 13, 2026NCT07869758Gastric On in Obesity Management: Evaluation of the Safety and Efficacy of the 6-Month Gastric Balloon (Prospective)Rigicon, Inc.Not applicableCompletedObesity & Overweight42Turkey (Türkiye)clinicaltrials.gov
October 9, 2026NCT07869290Benefits of Nutritional Supplement in Cancer CareThe Hong Kong Polytechnic UniversityNot applicableNot yet recruitingNutritional Deterioration, Malignant Solid Tumor, Cancer Cachexia, Cancer Malnutrition, Weight Loss, Oral Nutritional...100clinicaltrials.gov
October 9, 2026NCT07868939Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2)Viking Therapeutics, Inc.Phase 3Not yet recruitingWeight Loss560clinicaltrials.gov
October 9, 2026NCT07868835Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)Viking Therapeutics, Inc.Phase 3Not yet recruitingWeight Loss560clinicaltrials.gov
October 8, 2026NCT07866183Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative StudyNational Medical Research Center for Therapy and Preventive MedicineNot applicableRecruitingClass I Obesity120Russiaclinicaltrials.gov
October 1, 2026NCT07851714Metabolism and Nutrition in MNDGuy's and St Thomas' NHS Foundation TrustObservationalNot yet recruitingAmyotrophic Lateral Sclerosis (ALS), Motor Neurone Disease (MND)12United Kingdomclinicaltrials.gov
September 30, 2026NCT07850531Precision Nutrition for Obesity and Prediabetes Prevention in Under-supported CommunitiesPrairie View A&M UniversityNot applicableNot yet recruitingObesity & Overweight, Prediabetes100United Statesclinicaltrials.gov
September 29, 2026NCT07846865Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep ApnoeaWoolcock Institute of Medical ResearchPhase 2/3Not yet recruitingSleep Apnoea, Obesity & Overweight, Sleep Apnea Syndrome, Obstructive256Australiaclinicaltrials.gov
September 29, 2026NCT07846033A Phase 1 Study of VK3019 in Overweight and Obese Adults Without ComorbiditiesViking Therapeutics, Inc.Phase 1RecruitingObese Adults56United Statesclinicaltrials.gov
September 28, 2026NCT07844330Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese AdolescentsCentre Hospitalier Emile RouxNot applicableNot yet recruitingWeight Gain, Weight Loss, Eating Attitudes, Obese Adolescents18Franceclinicaltrials.gov
September 24, 2026NCT07838740A Phase 1 Study of VK2735 in Obese Adults Without ComorbiditiesViking Therapeutics, Inc.Phase 1RecruitingObese Adults270United Statesclinicaltrials.gov
September 21, 2026NCT07830329Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or...Regeneron PharmaceuticalsPhase 2Not yet recruitingHidradenitis Suppurativa300clinicaltrials.gov
September 21, 2026NCT07830121Very-Low-Carbohydrate Diet for Prediabetes and ObesityUniversiti Teknologi MaraNot applicableCompletedPrediabetes, Obesity / Overweight, VERY LOW CARBOHYDRATE DIET33Malaysiaclinicaltrials.gov
September 17, 2026NCT07824895Mazdutide for Weight Management and Gout in Adults With ObesityHongwei JiangPhase 4Not yet recruitingGout, Obesity (BMI>30), Hyperuricemia, Metabolic Syndrome30clinicaltrials.gov
September 16, 2026NCT07821554Personalised Nutritional Care in Older Patients With Pancreatic Ductal AdenocarcinomaInna Chen, MDNot applicableNot yet recruitingPancreatic Cancer250Denmark, Italy, Norway, Romania, Spainclinicaltrials.gov
September 15, 2026NCT07820358Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerThe Methodist Hospital Research InstitutePhase 2Not yet recruitingEndometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia, Endometrial...48United Statesclinicaltrials.gov
September 14, 2026NCT07818005Retrospective Continuous Glucose Monitor (CGM) Study on Glycemic Response and Body Composition in College StudentsHe Eye HospitalObservationalCompletedOverweight , Obesity, Weight Loss59Chinaclinicaltrials.gov
September 11, 2026NCT07815236Diabetes Prevention Through Genetics, Familial History and Behavior ChangeMorehouse School of MedicinePhase 2/3Not yet recruitingPrediabetes, Weight Loss400clinicaltrials.gov
September 10, 2026NCT07813429Changes in Cervical Posture, Cervical Function, and Neck Pain After Sleeve GastrectomyHaydarpasa Numune Training and Research HospitalObservationalRecruitingMorbid Obesity Requiring Bariatric Surgery, Neck Pain Musculoskeletal25Turkey (Türkiye)clinicaltrials.gov
September 9, 2026NCT07808723Georgia CEAL RESTORES Family Diabetes StudyMorehouse School of MedicineNot applicableRecruitingWeight Reduction, Prediabetes120United Statesclinicaltrials.gov
September 3, 2026NCT07803185Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor AgonistsTC Erciyes UniversityObservationalRecruitingObesity, Emotional Eating, Anhedonia60Turkey (Türkiye)clinicaltrials.gov
September 1, 2026NCT07796789Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal CarcinomaSun Yat-sen UniversityPhase 3RecruitingNasopharyngeal Cancinoma (NPC)204Chinaclinicaltrials.gov
September 1, 2026NCT07796503TSBL-Based Versus BMI-Based Biliopancreatic Limb Length in One-Anastomosis Gastric BypassNational Scientific Center of Surgery named after A.N.SyzganovNot applicableRecruitingMorbid Obesity, Obesity100Kazakhstanclinicaltrials.gov
August 31, 2026NCT07794566Longitudinal Changes in Lower Extremity Alignment and Mechanical Axis Parameters After Bariatric Surgery in Patients With Morbid Obesity: A...Marmara UniversityObservationalActive not recruitingObese, Limb Deformities, Arthritis30Turkey (Türkiye)clinicaltrials.gov
August 31, 2026NCT07794553Longitudinal Changes in Spinopelvic Alignment and Sagittal Balance After Bariatric Surgery in Patients With Morbid Obesity: A Prospective...Marmara UniversityObservationalActive not recruitingObesity, Spine Condition30Turkey (Türkiye)clinicaltrials.gov
August 28, 2026NCT07792954A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or...PfizerPhase 3RecruitingObesity, Overweight300Chinaclinicaltrials.gov
August 27, 2026NCT07789223Weight and Metabolic Management StudyElenziaNot applicableRecruitingOverweight, Obesity, Weight Maintenance200United Kingdomclinicaltrials.gov
August 21, 2026NCT07778550Effects of Diet, Exercise, and Electrical Muscle Stimulation in Overweight and Obese WomenDicle UniversityNot applicableCompletedObesity & Overweight75Turkey (Türkiye)clinicaltrials.gov
August 20, 2026NCT07777575Resistance Training to Prevent Muscle Loss During Treatment With TirzepatideTechnical University of MunichPhase 4RecruitingObesity (BMI>30)150Germanyclinicaltrials.gov
August 20, 2026NCT07775404A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2...AstraZenecaPhase 3RecruitingObesity, Overweight351China, Hong Kong, Malaysia, Philippines, Thailandclinicaltrials.gov
August 19, 2026NCT07774208FABP4 Response After Roux-en-Y Gastric BypassIstanbul UniversityObservationalCompletedObesity (BMI>30), Obesity (BMI > 35), Insulin Resistance, Bariatric Surgery, Bariatric Surgery (Gastric Bypass)28clinicaltrials.gov
August 18, 2026NCT07770893Acupoint Catgut Embedding With Laser Acupuncture for Weight Loss in Adults With ObesityTaipei City HospitalNot applicableNot yet recruitingObesity, Obesity, Abdominal, Overweight120Taiwanclinicaltrials.gov
August 11, 2026NCT07758387Polydextrose Functional Gummies for Weight Management in Adults With Overweight or ObesityNutris We Care About You S.L.Not applicableNot yet recruitingObesity & Overweight96Spainclinicaltrials.gov
July 31, 2026NCT07739095Weight Loss and HungerUniversity of OttawaNot applicableNot yet recruitingObesity & Overweight40Canadaclinicaltrials.gov
July 31, 2026NCT07738276Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart...Shahid Beheshti University of Medical SciencesPhase 3Not yet recruitingHeart Failure and Reduced Ejection Fraction, Obesity & Overweight, Tirzepatide60clinicaltrials.gov
July 30, 2026NCT07736547AIM-WEIGHT: AI-Guided Microbiome-Targeted Nutritional Intervention for Weight LossVarol TUNALINot applicableEnrolling by invitationOverweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Overweight (BMI > 25)80Turkey (Türkiye)clinicaltrials.gov
July 24, 2026NCT07724431A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and...HongKong Curegene Innovation Co., LimitedPhase 1Not yet recruitingOverweight and Obesity64Australiaclinicaltrials.gov
July 22, 2026NCT07720414Effects of GLP-1 RAs on Human Lactation OutcomesUniversity of Colorado, DenverObservationalRecruitingLactation, Weight Loss18United Statesclinicaltrials.gov
July 22, 2026NCT07718516Feasibility and Validation of a Smart Changing Pad for Home Infant Weight Monitoring After Hospital DischargeStan KachnowskiNot applicableCompletedInfant Nutrition Disorders, Weight Loss, Postnatal Care, Premature Birth12United Statesclinicaltrials.gov
July 14, 2026NCT07703358Effect of Chromium Weight Reduction on Adult Asthma ControlCairo UniversityNot applicableNot yet recruitingAsthma Chronic, Bronchial Asthma60clinicaltrials.gov
July 14, 2026NCT07702461Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor AgonistsOhio State UniversityObservationalRecruitingObesity & Overweight, Diabetes (DM)300United Statesclinicaltrials.gov
July 13, 2026NCT07700030High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE)NYU Langone HealthNot applicableNot yet recruitingWeight Loss32United Statesclinicaltrials.gov
July 9, 2026NCT07693491Sleep Evaluation Before and After Metabolic SurgeryCatharina Ziekenhuis EindhovenObservationalNot yet recruitingObesity & Overweight, Obesity & Overweight Sleep, Sleep, Metabolic Surgery50Netherlandsclinicaltrials.gov
July 9, 2026NCT07693426Phase Ib Study of Efsubaglutide Alfa Injection in Obese AdolescentsShanghai Yinnuo Pharmaceutical Technology Co., Ltd.Phase 1RecruitingAdolescence Obesity36Chinaclinicaltrials.gov
July 8, 2026NCT07690592A Single-arm Pilot Feasibility Trial of Healthy PrideUniversity of ConnecticutNot applicableNot yet recruitingObesity & Overweight40clinicaltrials.gov
July 6, 2026NCT07685834Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight LossSofwave Medical LTDNot applicableActive not recruitingLax Skin30Canadaclinicaltrials.gov
June 30, 2026NCT07674875Meal Frequency and Timing on Metabolic Health in Patients With Type 2 DiabetesAkdeniz UniversityNot applicableCompletedType 2 Diabetes, Obesity and Overweight144Turkey (Türkiye)clinicaltrials.gov
June 23, 2026NCT07663942Targeting Sedentary Behavior Reduction and Physical Fitness Enhancement in Women Before and Beyond Bariatric Surgery- BARIMOV Study ProtocolHospital de Sao SebastiaoNot applicableRecruitingObesity (Disorder)72Portugalclinicaltrials.gov
June 23, 2026NCT07663630A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight LossPfizerPhase 1Not yet recruitingNon-small Cell Lung Cancer (NSCLC), Cachexia80China, United Statesclinicaltrials.gov
June 18, 2026NCT07657286Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease PatientsBadr UniversityNot applicableRecruitingChronic Kidney Disease, Diabetes60Egyptclinicaltrials.gov
June 18, 2026NCT07655739The Effects of Sleeve Gastrectomy on FractalkineMehmet Buğra BozanObservationalCompletedObesity & Overweight40Turkey (Türkiye)clinicaltrials.gov
June 17, 2026NCT07654062Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)Shandong Provincial HospitalPhase 4Not yet recruitingPrediabetes, Impaired Fasting Glucose, Impaired Glucose Tolerance (Prediabetes)150Chinaclinicaltrials.gov
June 15, 2026NCT07647991The IGBallon (R) - for Use in the Treatment of ObesityMedical University of ViennaNot applicableCompletedWeight Loss, Adverse Events, Comorbidities5Austriaclinicaltrials.gov
June 10, 2026NCT07638592Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With ObesityAzienda Sanitaria Locale Napoli 2 NordObservationalCompletedObese Adults, Hernia Abdominal Wall, Prehabilitation91Italyclinicaltrials.gov
June 9, 2026NCT07636395Eating Behaviour Before, During, and After Obesity MedicationUniversity College DublinObservationalRecruitingObesity Type 2 Diabetes Mellitus, Obesity & Overweight30Irelandclinicaltrials.gov
June 9, 2026NCT07636239Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric SurgeryÖzlem ÖZPAK AKKUŞObservationalNot yet recruitingObesity, Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, Eating Behavior, Nutritional Status40Turkey (Türkiye)clinicaltrials.gov
June 4, 2026NCT07627256Weight Loss Composition and Metabolic Adaptation During Hypocaloric DietingTel Aviv UniversityNot applicableNot yet recruitingObesity150clinicaltrials.gov
June 2, 2026NCT07621640Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)Hallym UniversityNot applicableNot yet recruitingObesity, Metabolic Syndrome, Brown Adipose Tissue80South Koreaclinicaltrials.gov
June 1, 2026NCT07616752The Impact of Salmon Protein Hydrolysate (SPH / ProGo®) Supplementation on Hematologic and Metabolic HealthHofseth Biocare ASANot applicableCompletedOverweight (BMI > 25), Weight Loss14Indiaclinicaltrials.gov
May 29, 2026NCT07614178Effects of a Soya-Based Fibre Beverage on Weight and Health in Overweight AdultsUniversiti Sains MalaysiaNot applicableCompletedOverweight Adults42Malaysiaclinicaltrials.gov
May 28, 2026NCT07611552Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications...Huazhong University of Science and TechnologyNot applicableNot yet recruitingObesity & Overweight600Chinaclinicaltrials.gov
May 27, 2026NCT07608016A Study to Evaluate a Supplement Combination in Supporting Weight Loss, Metabolic Health, and Quality of LifeAble Biolabs, LLCNot applicableCompletedWeight Loss, Metabolic Health, Quality of Life20United Statesclinicaltrials.gov
May 22, 2026NCT07605169Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)Vastra Gotaland RegionNot applicableActive not recruitingOverweight, Obesity, Prediabetic State103Swedenclinicaltrials.gov
May 22, 2026NCT07602803The Effect of GLP1 Agonists on Weight Loss in BBS Cohort in the UKThe Queen Elizabeth HospitalObservationalCompletedBardet-Biedl Syndrome300United Kingdomclinicaltrials.gov
May 22, 2026NCT07601061Simplifying Diet Tracking in a Digital Weight Loss InterventionStanford UniversityNot applicableNot yet recruitingOverweight, Obesity, Weight Loss, Health Behavior, Lifestyle Intervention328United Statesclinicaltrials.gov
May 18, 2026NCT07592546Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossAlain DagherPhase 4RecruitingClass I/II Obesity240Canadaclinicaltrials.gov
May 15, 2026NCT07588984GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort StudyNoom Inc.ObservationalNot yet recruitingObesity & Overweight, Weight Loss, Preventative Health, Body Weight, Cardiovascular Disease Risk Factor2,310United Statesclinicaltrials.gov
May 14, 2026NCT07588438Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.Las Rías Medical CenterPhase 4RecruitingObesity, Diabetes Mellitus, Type 2160Paraguayclinicaltrials.gov
May 13, 2026NCT07582536Optimization of Dietary Adherence in a Mobile Weight Loss InterventionUNC Lineberger Comprehensive Cancer CenterNot applicableNot yet recruitingOverweight and/or Obesity580United Statesclinicaltrials.gov
May 11, 2026NCT07577765Testing a Tailored Approach to Long-Term Weight Loss SuccessUniversity of UtahNot applicableRecruitingWeight Loss, Weight Regain, Obesity & Overweight30United Statesclinicaltrials.gov
May 8, 2026NCT07576777Hormonal and Microbiota Modulation After Endoscopic Sleeve GastroplastyAssistance Publique - Hôpitaux de ParisNot applicableNot yet recruitingObesity (Disorder), Metabolic Disorders40Franceclinicaltrials.gov
May 6, 2026NCT07569172Improved Child Nutrition and Development Through Social TransfersSwiss Tropical & Public Health InstituteNot applicableNot yet recruitingBreastfeeding, Breastfeeding Education, Breastfeeding Duration, Breastfeeding Continuation, Child Growth, Stress...1,040Côte d’Ivoireclinicaltrials.gov
May 5, 2026NCT07567937Effects of Exercise and Short Term Rapid Weight Loss on Whole Blood Cells and Lymphocyte Subsets in Highly Trained National Level WrestlersAnkara Yildirim Beyazıt UniversityNot applicableCompletedWeight Loss, Exercise9Turkey (Türkiye)clinicaltrials.gov
May 1, 2026NCT07560969Addressing Food Access and Physical Activity to Improve Diabetes Prevention Outcomes Among Underserved African AmericansUniversity of Missouri, Kansas CityNot applicableNot yet recruitingDiabetes, Physical Activity, Food Security, Nutrition Security408United Statesclinicaltrials.gov
May 1, 2026NCT07560579Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With...Million Marker Wellness, Inc.Not applicableActive not recruitingObesity &Amp;Amp;Amp; Overweight, Environmental Exposure, Overweight (BMI > 25)226United Statesclinicaltrials.gov
April 30, 2026NCT07558603Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1...Goldman, Butterwick, Fitzpatrick and GroffNot applicableNot yet recruitingLaxity; Skin50United Statesclinicaltrials.gov
April 28, 2026NCT07553299A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With...Verdiva Bio Dev LimitedPhase 2TerminatedObesity, Overweight, Weight Maintenance8United Statesclinicaltrials.gov
April 23, 2026NCT07547722Effect of a High-Protein Diet With Meal Replacements on Weight LossKazakh Academy of NutritionNot applicableActive not recruitingObesity & Overweight60Kazakhstanclinicaltrials.gov
April 21, 2026NCT07541872Weight Loss Goals and Satisfaction SurveyPennington Biomedical Research CenterObservationalNot yet recruitingOverweight and Obesity250clinicaltrials.gov
April 20, 2026NCT07540754A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic FunctionFujian Shengdi Pharmaceutical Co., Ltd.Phase 1RecruitingDiabetes Mellitus, Weight Loss24Chinaclinicaltrials.gov
April 17, 2026NCT07535892Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication DiscontinuationUniversity of Alabama at BirminghamNot applicableNot yet recruitingWeight Loss, GLP - 1, Weight Loss Maintenance, Obesity & Overweight64United Statesclinicaltrials.gov
April 16, 2026NCT07534254Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss ProgramUniversity of North Carolina, Chapel HillNot applicableActive not recruitingOverweight and/or Obesity20United Statesclinicaltrials.gov
April 15, 2026NCT07530718Body Composition Outcomes in MS PatientsPennington Biomedical Research CenterObservationalRecruitingObesity20United Statesclinicaltrials.gov
April 6, 2026NCT07513168Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani AdultsAsian Institute Of Medical SciencesPhase 4RecruitingObesity, Weight Reduction, Cardiometabolic Risk Factors60Pakistanclinicaltrials.gov

Sponsors posting most

SponsorNew trialsLatest
Viking Therapeutics, Inc.7October 9, 2026
Pfizer5October 15, 2026
University of Colorado, Denver4November 2, 2026
University of Alabama at Birmingham4April 17, 2026
Boston Scientific Corporation4December 11, 2025
Pennington Biomedical Research Center3April 21, 2026
General Committee of Teaching Hospitals and Institutes, Egypt3February 27, 2026
University of Texas Southwestern Medical Center3January 23, 2026
Clinica Universidad de Navarra, Universidad de Navarra3September 10, 2025
BTL Industries Ltd.3April 4, 2025
McMaster University2October 28, 2026
Eli Lilly and Company2October 22, 2026
Centre Hospitalier Universitaire, Amiens2October 20, 2026
Morehouse School of Medicine2September 11, 2026
Marmara University2August 31, 2026
Cairo University2July 14, 2026
NYU Langone Health2July 13, 2026
Medical University of Vienna2June 15, 2026
Tel Aviv University2June 4, 2026
Vastra Gotaland Region2May 22, 2026

By phase

PhaseNew trialsLatest
Not applicable144November 9, 2026
Observational46November 2, 2026
Phase 420November 3, 2026
Phase 218November 2, 2026
Phase 313October 15, 2026
Phase 112September 29, 2026
Phase 2/36October 22, 2026
Phase 1/21October 27, 2026

By country

CountryNew trialsLatest
United States102November 2, 2026
China25October 15, 2026
Turkey (Türkiye)18October 28, 2026
Canada11October 28, 2026
Spain11September 16, 2026
Italy9September 16, 2026
France7October 20, 2026
United Kingdom7October 1, 2026
Egypt7June 18, 2026
Germany6November 9, 2026
Czechia4November 3, 2026
Denmark4November 2, 2026
Australia4September 29, 2026
Taiwan4August 18, 2026
Netherlands4July 9, 2026
Poland3November 3, 2026
Malaysia3September 21, 2026
Norway3September 16, 2026
Mexico3March 6, 2026
Israel3February 17, 2026
Bulgaria3August 8, 2025
Switzerland3August 8, 2025
Puerto Rico3August 5, 2025
Romania2September 16, 2026
Kazakhstan2September 1, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.